Oscar Health, Inc. (OSCR) Q3 2024 Earnings Conference Call Transcript
Portfolio Pulse from
Oscar Health, Inc. (OSCR) held its Q3 2024 earnings conference call on November 7, 2024. Key participants included CEO Mark Bertolini and CFO Scott Blackley. The call involved discussions with analysts from Wells Fargo, Raymond James, Piper Sandler, Nephron Research, Baird, and Bank of America.
November 09, 2024 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oscar Health's Q3 2024 earnings call provided insights from top executives and engaged with analysts from major financial institutions, potentially influencing investor sentiment.
The earnings call is a regular event that provides updates on the company's financial performance and strategic direction. The presence of top executives and analysts suggests that the call could influence investor sentiment, but without specific financial results or guidance, the immediate impact on stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100